Linqi Liu

Linqi Liu

Auto-generated profile, based on publicly available information

Linqi Liu

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University , No. 2 Anzhen Road, Chaoyang District, Beijing 100029

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2026 in Circulation Research
Verified
Journal Article
Closed access
YPYilin Pan
Yilin Pan
LLLinqi Liu
Linqi Liu
JLJiyuan Luo
Jiyuan Luo
XZXiaozheng Zhou
Xiaozheng Zhou
YWYu Wang
Yu Wang
XYXiubin Yang
Xiubin Yang
BACKGROUND: Micro(nano)plastics (MNPs) are pervasive environmental contaminants, yet their presence in human cardiac tissue and their potential contribution to myocardial fibrosis remain unclear. We investigated whether myocardial MNP burden is associated with fibrosis severity in patients and evaluated mechanistic plausibility in mice. METHODS: Left atrial appendage tissues were collected from patients undergoing cardiac surgery (n=33). MNP burden and polymer composition were quantified by pyrolysis-gas chromatography/mass spectrometry, and fibrosis was quantified histologically. In mice, 100-nm or 1-µm polystyrene nanoplastics were administered by oral gavage in coexposure and sequential exposure protocols with isoprenaline. Cardiac function was assessed by echocardiography, and fibrosis was evaluated by histology and immunohistochemistry. Transcriptomics, metabolomics, and 16S ribosomal RNA sequencing were performed to identify pathways linked to MNP exposure. RESULTS: MNPs were detected in all human cardiac samples. Patients with high fibrosis exhibited higher total MNP levels than those with low fibrosis (171.74 [interquartile range [IQR], 158.18–202.39] versus 119.33 [IQR, 102.75–148.44] µg/g tissue; P =2.5×10 – 4 ), driven predominantly by elevated nanoplastics (122.83 [IQR, 100.10–149.06] versus 86.39 [IQR, 36.85–103.74] µg/g; P =0.010). Polystyrene and polyvinyl chloride were enriched in high-fibrosis tissues (polystyrene: P =3.3×10 – 4 ; polyvinyl chloride: P =0.002). Transcriptomics indicated activation of inflammatory and profibrotic pathways (TNF [tumor necrosis factor]/NF-κB [nuclear factor-κB], TGF-β [transforming growth factor-beta], and MAPK [mitogen-activated protein kinase]), supported by increased α-SMA (alpha-smooth muscle actin), COL1 (collagen I), and TGF-β1 immunostaining, while metabolomics suggested perturbations in lipid metabolism and mitochondrial function. In mice, polystyrene exposure exacerbated isoprenaline-induced systolic dysfunction and myocardial fibrosis in both experimental paradigms and recapitulated pathway signatures related to cell-matrix interactions. CONCLUSIONS: Myocardial MNP burden, particularly nanoplastics, is associated with greater fibrosis in humans, and experimental polystyrene exposure aggravates stress-induced myocardial remodeling in vivo. Multiomics analyses nominate inflammatory, ECM (extracellular matrix), and metabolic programs as candidate mediators of MNP-associated cardiotoxicity.

10 October 2026 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
LLLinqi Liu
Linqi Liu
YPYilin Pan
Yilin Pan
JJJie Ji
Jie Ji
HGHai Gao
Hai Gao
YRYanlong Ren
Yanlong Ren
XSXiantao Song
Xiantao Song
Aims: Identifying the infarct-related artery (IRA) before coronary angiography in non–ST-segment elevation myocardial infarction (NSTEMI) is difficult because current approaches have limited sensitivity. We evaluated whether a non-invasive 90-s optically pumped magnetometer magnetocardiography (OPM-MCG) recording can estimate pre-angiography IRA probabilities in these patients and provide information beyond standard-care variables. Methods and results: This prospective two-campus study within one hospital system included a Campus 1 development cohort (n = 493) and a geographically separate Campus 2 test cohort (n = 118). All patients underwent OPM-MCG before angiography. An XGBoost model using 65 prespecified OPM-MCG features was developed with nested cross-validation, locked, and evaluated once in Campus 2. IRA adjudication followed a core-laboratory hierarchy. Discrimination, calibration, and clinical utility were compared with ECG and TTE. Among 611 patients, 43% had LAD, 23% LCx, and 34% RCA IRA. In Campus 2, overall accuracy was 63.6%, macro-F1 was 60.0%; LAD/LCx/RCA vessel-specific areas under the receiver operating characteristic curve were 0.87/0.79/0.79 and top-1 sensitivity was 76.6%/34.5%/69.0%. Accuracy was 51.7% for matched ECG-only XGBoost and 55.9% for integrated standard care. In an exploratory stacked analysis, adding locked OPM-MCG probabilities to standard care increased accuracy to 67.8% (paired difference 11.9%, 95% CI 4.2–19.5; P = 0.008). Conclusion: In haemodynamically stable patients with NSTEMI already selected for invasive management, a locked OPM-MCG model provided informative vessel-level probabilities in Campus 2 and complementary signal with standard care. Performance was strongest for LAD and RCA. Prospective multicentre, cross-platform testing is needed before clinical use. Trial registration number: ChiCTR2300070211.